Providing HIV medication to both members of a HIV-serodiscordant couple substantially reduced the risk of transmission within that couple, according to a
Increasingly, people at risk for HIV infection are turning to preventive drug measures to help stave off the virus.
New data analyses finds that a monthly vaginal ring containing an antiretroviral drug called dapivirine can cut women’s HIV risk by more than half and, in some, by 75 percent or more.
Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.
[See related KOMO-4 News' Dec. 1 story.]
Two University of Washington faculty aim to develop an injectable HIV therapy that can be administered once a week, easing the regimen of daily pills that HIV-positive people must manag
Visitors to the AIDS Outreach Clinic in Bozeman, Montana usually come alone, or sometimes with a friend.
She’s won awards for pioneering approaches to pharmacy, but UW faculty member Elyse Tung remains modest about her work.
In a basement lab deep within the Magnuson Health Sciences Building, a group of scientists works to decode the mysteries of two deadly viruses: influenza and HIV.
The persistence of HIV infection despite antiretroviral treatment depends partly on which human genes the virus integrates, according to a new study by the University of Washi